ArticleTranslational vision science & technology2026
Refined Four-Layer Peripapillary OCTA Enables Layer-Specific Localization of Microvascular Alterations in Retinal Vein Occlusion.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate whether refined four-layer anatomical stratification of the peripapillary microvasculature improves anatomical localization, optical coherence tomography angiography (OCTA)-based discriminative performance, and functional interpretation in newly diagnosed, treatment-naïve retinal vein occlusion (RVO). Methods: This cross-sectional study included 186 eyes (72 RVO-affected, 72 fellow, and 42 healthy eyes). Peripapillary microvasculature was quantified across three hierarchical dimensions: global (Dim 1), two-layer (Dim 2), and a refined four-layer model (Dim 3: RPC, SVP, ICP, and DCP). Microvascular metrics, including vessel density (VD), fractal dimension (FD), perfusion area (PA), vessel length density (VLD), and vessel diameter index (VDI), were quantified. Discriminative performance was assessed with area under the curve (AUC) and AIC, whereas functional associations with visual acuity (BCVA) were evaluated using regression analysis. Results: Standardized disease contrasts for VD were -0.57 in the global inner retina, -0.83 in the conventional deep vascular complex (DVC), and -0.79 in the DCP. Corresponding FD contrasts were -0.07, -0.39, and -0.39, respectively, indicating that DCP isolation did not increase standardized disease contrast beyond the conventional DVC. However, refined four-layer stratification improved anatomical localization of deep-layer abnormalities and enhanced OCTA-based discriminative performance (AUC: VD, 0.636 to 0.826; FD, 0.603 to 0.807; both P < 0.05). FD-based models showed stronger associations with BCVA (adjusted R², 0.021 to 0.211), with DCP-related metrics contributing substantially to model performance. Conclusions: Refined four-layer peripapillary OCTA enables more specific localization of layer-related abnormalities in RVO. Although DCP isolation did not increase standardized disease contrast beyond the conventional DVC, DCP-resolved metrics, particularly FD, may provide complementary information regarding vascular network organization and visual function. Translational Relevance: Plexus-resolved peripapillary OCTA may support more anatomically specific characterization of RVO-related microvascular abnormalities and provide a methodological framework for future longitudinal and externally validated studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.